NCT02282085View on ClinicalTrials.gov

Treatment Study Comparing Aripiprazole Once Monthly With Standard of Care Medication in Outpatients With Schizophrenia

PHASE4UnknownINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

December 31, 2017

Conditions
Schizophrenia
Interventions
DRUG

Aripiprazole Once-Monthly

DRUG

Oral Antipsychotic (i.e. aripiprazole, risperidone, lurasidone, quetiapine, olanzapine, ziprasidone, etc)

Oral antipsychotic medication

Trial Locations (1)

75390

RECRUITING

UT Southwestern Medical Center, Dallas

Sponsors
All Listed Sponsors
collaborator

Otsuka America Pharmaceutical

INDUSTRY

lead

Matt Byerly

OTHER